Metabolomics of Diabetes in Pregnancy.
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Purpose of review The purpose of this review is to describe ways in which metabolomics may enhance understanding of gestational diabetes mellitus (GDM) etiology and refine current diagnostic criteria. Recent findings Current clinical recommendations suggest screening for GDM between 24 and 28 of gestational weeks using an oral glucose tolerance test. Despite this consensus, there are discrepancies regarding the exact criteria for GDM diagnosis. Further, emerging evidence has unveiled heterogeneous physiological pathways underlying GDM-specifically, GDM with defective insulin secretion vs. sensitivity-that have important implications for disease diagnosis and management. The objectives of this review are threefold. First, we seek to provide a brief summary of current knowledge regarding GDM pathophysiology. Next, we describe the potential role of metabolomics to refine and improve the prediction, screening, and diagnosis of GDM. Finally, we propose ways in which metabolomics may eventually impact clinical care and risk assessment for GDM and its comorbidities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This was consistent with the independent and additive effects of maternal obesity and gestational diabetes on newborn adiposity outcomes in the HAPO Study.32”
From Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity (2018) · cites this paper as [32]
Citations
Cites
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Metabolite profiles and the risk of developing diabetes
Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2307 · Cited by 3,143
Gestational Diabetes and the Incidence of Type 2 Diabetes
Kim, C., Newton, K. M., & Knopp, R. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1862 · Cited by 2,276
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Buchanan, T. A., & Xiang, A. H. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524531 · Cited by 2,123
Increasing Prevalence of Gestational Diabetes Mellitus
Ferrara, A. (2007) · Diabetes Care · doi:10.2337/dc07-s206 · Cited by 1,171
Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.
Stumvoll, M., Mitrakou, A., Pimenta, W., Jenssen, T., Yki-Järvinen, H., Van Haeften, T., Renn, W., & Gerich, J. (2000) · Diabetes Care · doi:10.2337/diacare.23.3.295 · Cited by 1,042
K-Profiles: A Nonlinear Clustering Method for Pattern Detection in High Dimensional Data
Wang, K., Zhao, Q., Lu, J., & Yu, T. (2015) · BioMed Research International · doi:10.1155/2015/918954 · Cited by 989
American Diabetes Association (2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s88 · Cited by 916
Research works printed but not linked: 1
- Buchanan TA. Metabolic changes during normal and diabetic pregnancy. In: Reece E, Coustan D, editors. Diabetes Mellit. Pregnancy. New York: Churchill Livingstone; 1995. p. 59–77.
Cited by
Lowe, W. L., Scholtens, D. M., Lowe, L. P., Kuang, A., Nodzenski, M., Talbot, O., Catalano, P. M., Linder, B., Brickman, W. J., Clayton, P., et al. (2018) · JAMA · doi:10.1001/jama.2018.11628 · Cited by 591
“However, recentmetabolomics studiesperformedwithin theHAPOStudy andwithin other cohorts support the concept that mixed nutrients (eg, sugars, lipids, and amino acids) contribute to associations ofmaternal hyperglycemia with newborn outcomes.(34,35) This study had several strengths.”
BackgroundWang, Y., Huang, Y., Wu, P., Ye, Y., Sun, F., Yang, X., Lu, Q., Yuan, J., Liu, Y., Zeng, H., et al. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab242 · Cited by 109
Preliminary metabolomics analysis of placenta in maternal obesity
Fattuoni, C., Mandò, C., Palmas, F., Anelli, G. M., Novielli, C., Laudicina, E. P., Savasi, V. M., Barberini, L., Dessì, A., Pintus, R., et al. (2017) · Placenta · doi:10.1016/j.placenta.2017.11.014 · Cited by 83
“Most of these works reported metabolomic analysis of 15 bio-fluids such as blood, urine or amniotic fluid [7-13].”
BackgroundMethodLeitner, M., Fragner, L., Danner, S., Holeschofsky, N., Leitner, K., Tischler, S., Doerfler, H., Bachmann, G., Sun, X., Jaeger, W., et al. (2017) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2017.00084 · Cited by 71
“This workflow reveals the power of metabolomics screening of metabolic diseases, especially in the context of physiological interpretation of identified significant changes in metabolites (McCabe and Perng, 2017).”
BackgroundZhao, H., Li, H., Chung, A. C. K., Xiang, L., Li, X., Zheng, Y., Luan, H., Zhu, L., Liu, W., Yang, P., et al. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00602 · Cited by 83
Metadata
- Authors
- McCabe, C. F., & Perng, W.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Perng, Wei
- Venue
- Current Diabetes Reports
- Published
- 2017-06-23
- Volume
- 17
- Issue
- 8
- Pages
- 57-57
- ISSN
- 1534-4827 (ISSN-L)
- 1539-0829
- OpenAlex
- W2666696061
- Cited by
- 41
- References
- 61
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 7 · 2021: 5 · 2020: 5 · 2019: 6 · 2018: 5 · 2017: 3
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Diabetes Reports (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- gestational diabetes mellitus, metabolomics, GDM screening, oral glucose tolerance test, insulin secretion, insulin sensitivity, risk assessment
- MeSH terms
- Female, Glucose Tolerance Test, Humans, Infant, Pregnancy, Pregnancy Outcome, Diabetes, Gestational, Metabolomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabolomics of Diabetes in Pregnancy. https://app.cochat.ai/papers/10.1007/s11892-017-0890-3
- The paper
- McCabe, C. F., & Perng, W. (2017). Metabolomics of Diabetes in Pregnancy. Current Diabetes Reports. https://doi.org/10.1007/s11892-017-0890-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.